Julio Cesar Cetrulo Lorenzi

Cited by

	All	Since 2018
Citations	12055	11053
h-index	37	36
i10-index	56	53

3900

1950

975

2925

2013201420152016201720182019202020212022202335 35 143 295 407 519 566 1194 3848 3109 1710

Public access

View all

45 articles

1 article

available

not available

Based on funding mandates

Co-authors

michel nussenzweigHHMI, The Rockefeller UniversityVerified email at rockefeller.edu
Thiago Yukio Kikuchi OliveiraRockefeller UniversityVerified email at rockefeller.edu
Arlete A. M. Coelho CasteloProfessor of School of Medicine, USP, BrazilVerified email at fmrp.usp.br
Pamela J BjorkmanCentennial Professor of Biology and Biological EngineeringVerified email at caltech.edu
DALILA ZANETTEInstituto Carlos Chagas (ICC)/Fiocruz ParanáVerified email at fiocruz.br
Ching-Lan LuThe Rockefeller UniversityVerified email at med.cornell.edu
Ana Paula Fávaro TromboneProfessora Auxiliar I - Universidade do Sagrado CoraçãoVerified email at usc.br
Thiago MalardoDoutor formado pela Faculdade de Medicina de Ribeirão Preto, Universidade de São PauloVerified email at usp.br
John P BartonAssociate Professor, Department of Computational and Systems Biology, University of PittsburghVerified email at pitt.edu
Luciana Previato de AlmeidaOklahoma Medical Research FoundationVerified email at omrf.org
Renata RossettiMoffitt Cancer CenterVerified email at moffitt.org
Amilton Antunes BarreiraProfessor of Neurology, University of São PauloVerified email at fmrp.usp.br
Beatrice H. Hahn, MDProfessor of Medicine and Microbiology, University of PennsylvaniaVerified email at upenn.edu
Rodrigo Alexandre PanepucciPesquisador Científico e Tecnológico, Fundação Hemocentro de Ribeirão Preto, HC-FMRP-USPVerified email at hemocentro.fmrp.usp.br
Bruna Rodrigues MuysNCIVerified email at nih.gov
Luiza Ferreira Araujo, PhDAC Camargo Cancer CenterVerified email at accamargo.org.br
Marisa A. LimaDoutoranda do Instituto de Física de São Carlos, Universidade de São PauloVerified email at usp.br
Tereza Cristina OrlandoInstituto de Ciências da NaturezaVerified email at unifal-mg.edu.br
Dimas Tadeu CovasUniversity of Sao Paulo - USP - BrazilVerified email at fmrp.usp.br
Doralina G. BrumFaculdade de Medicina de Botucatu da Universidade Estadual Paulista "Júlio de Mesquita Filho"Verified email at unesp.br

Julio Cesar Cetrulo Lorenzi

Principal Scientist

Verified email at modernatx.com - Homepage

Vaccine development B cell biology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Convergent antibody responses to SARS-CoV-2 in convalescent individuals DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ... Nature 584 (7821), 437-442, 2020	1870	2020
Evolution of antibody immunity to SARS-CoV-2 C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ... Nature 591 (7851), 639-644, 2021	1547	2021
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston, JCC Lorenzi, ... elife 9, e61312, 2020	1391	2020
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117 M Caskey, F Klein, JCC Lorenzi, MS Seaman, AP West Jr, N Buckley, ... Nature 522 (7557), 487-491, 2015	771	2015
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies CO Barnes, AP West, KE Huey-Tubman, MAG Hoffmann, NG Sharaf, ... Cell 182 (4), 828-842. e16, 2020	715	2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses F Schmidt, Y Weisblum, F Muecksch, HH Hoffmann, E Michailidis, ... Journal of Experimental Medicine 217 (11), e20201181, 2020	513	2020
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption JF Scheid, JA Horwitz, Y Bar-On, EF Kreider, CL Lu, JCC Lorenzi, ... Nature 535 (7613), 556-560, 2016	455	2016
Combination therapy with anti-HIV-1 antibodies maintains viral suppression P Mendoza, H Gruell, L Nogueira, JA Pai, AL Butler, K Millard, ... Nature 561 (7724), 479-484, 2018	421	2018
Enhanced SARS-CoV-2 neutralization by dimeric IgA Z Wang, JCC Lorenzi, F Muecksch, S Finkin, C Viant, C Gaebler, ... Science translational medicine 13 (577), eabf1555, 2021	380	2021
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques M Shingai, OK Donau, RJ Plishka, A Buckler-White, JR Mascola, ... Journal of Experimental Medicine 211 (10), 2061-2074, 2014	346	2014
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1 T Schoofs, F Klein, M Braunschweig, EF Kreider, A Feldmann, L Nogueira, ... Science 352 (6288), 997-1001, 2016	328	2016
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo A Schäfer, F Muecksch, JCC Lorenzi, SR Leist, M Cipolla, S Bournazos, ... Journal of Experimental Medicine 218 (3), e20201993, 2020	284	2020
Longitudinal serological analysis and neutralizing antibody levels in coronavirus disease 2019 convalescent patients F Muecksch, H Wise, B Batchelor, M Squires, E Semple, C Richardson, ... The Journal of infectious diseases 223 (3), 389-398, 2021	256	2021
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations F Muecksch, Y Weisblum, CO Barnes, F Schmidt, D Schaefer-Babajew, ... Immunity 54 (8), 1853-1868. e7, 2021	215	2021
Planejamento, montagem e aplicação de modelos didáticos para abordagem de biologia celular e molecular no ensino médio por graduandos de ciências biológicas TC Orlando, AR Lima, AM da Silva, CN Fuzissaki, CL Ramos, D Machado, ... Revista de Ensino de Bioquímica 7 (1), 1-17, 2009	187	2009
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA JCC Lorenzi, YZ Cohen, LB Cohn, EF Kreider, JP Barton, GH Learn, ... Proceedings of the National Academy of Sciences 113 (49), E7908-E7916, 2016	184	2016
Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis J Lorenzi, A Trombone, C Rocha, L Almeida, R Lousada, T Malardo, ... BMC biotechnology 10 (1), 77, 2010	163	2010
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller Science Translational Medicine 9 (373), eaal2144, 2017	157	2017
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants J Xu, K Xu, S Jung, A Conte, J Lieberman, F Muecksch, JCC Lorenzi, ... Nature 595 (7866), 278-282, 2021	144	2021
Non-neutralizing antibodies alter the course of HIV-1 infection in vivo JA Horwitz, Y Bar-On, CL Lu, D Fera, AAK Lockhart, JCC Lorenzi, ... Cell 170 (4), 637-648. e10, 2017	141	2017

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors